Regulatory Open Forum

 View Only
  • 1.  Pre-IND meeting request via secure email - COVID19

    This message was posted by a user wishing to remain anonymous
    Posted 19-May-2020 11:20
    This message was posted by a user wishing to remain anonymous

    Hello,

    We are working with an investigator who would like to submit a Pre-IND meeting request for a COVID19 related program at the earliest. Since contracting with an eCTD vendor is taking time, we are thinking if we could submit the briefing material via email.

    Has anyone submitted a pre-ind meeting request via email? If yes, in order to establish a secure email, did you first obtain a digital certificate prior to sending a S/MIME request (SecureEmail@fda.hhs.gov)? 

    Any input or guidance is appreciated.

    Thank you.


  • 2.  RE: Pre-IND meeting request via secure email - COVID19

    Posted 20-May-2020 09:46
    I recommend that you contact the Project Manager of the Division to whom you intend to submit the request by telephone. FDA is very responsive to COVID-19 development requests. While you can send the meeting request by email, FDA does not consider it a formal submission, but I wouldn't let that stop you at this point. Get the PMs advice. They are flexible.

    ------------------------------
    Glen Park PharmD
    Executive Director, Regulatory Affairs and Quality Assurance
    Jersey City NJ
    United States
    ------------------------------



  • 3.  RE: Pre-IND meeting request via secure email - COVID19

    This message was posted by a user wishing to remain anonymous
    Posted 03-Jun-2020 08:33
    This message was posted by a user wishing to remain anonymous

    Thank you so much!


  • 4.  RE: Pre-IND meeting request via secure email - COVID19

    Posted 20-May-2020 10:38
    FDA is allowing the use of their NextGen Portal for Pre-IND submissions/communications. Go to the following website and read down to the bottom of the page. You will see that Option 2 is a route you can use without going through the Gateway.

    https://www.fda.gov/drugs/coronavirus-covid-19-drugs/drug-development-inquiries-drugs-address-covid-19-public-health-emergency

    Ric


    ------------------------------
    Richard Newman PhD
    Principal
    Deerfield IL
    United States
    ------------------------------



  • 5.  RE: Pre-IND meeting request via secure email - COVID19

    This message was posted by a user wishing to remain anonymous
    Posted 03-Jun-2020 08:33
    This message was posted by a user wishing to remain anonymous

    Thank you very much, Richard. This is really helpful.


  • 6.  RE: Pre-IND meeting request via secure email - COVID19

    Posted 20-May-2020 10:40
    If the product falls under CDER, you can submit the pre-IND meeting request as a PDF file via the FDA NextGen portal as an FDA Alternate Submission. 
    https://edm.fda.gov/EDMIDPLogin/welcome?response_type=code&client_id=0oa1as7rb2poiYTch297&scope=openid%20profile&state=-1283440619_1589985366196&redirect_uri=https%3A%2F%2Fedm.fda.gov%2Foidcclient%2Fedmrp

    Good luck!

    ------------------------------
    Bridgette Kunst RAC, MA
    Managing Director
    bkunst@bridgereg.com
    ------------------------------



  • 7.  RE: Pre-IND meeting request via secure email - COVID19

    This message was posted by a user wishing to remain anonymous
    Posted 03-Jun-2020 08:33
    This message was posted by a user wishing to remain anonymous

    Thank you for sharing, Bridgette.